Contact our breast care nurses
0808 800 6000
Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "Today's approval of palbociclib with fulvestrant for routine use...
Responding to research published in the BMJ about minimum tumour free margins in breast cancer surgery, Jane Murphy, Senior Clinical Nurse...
In response to new research published in the British Journal of Sports Medicine about physical activity and breast cancer risk, Dr Kotryna...
Following internal NHS data seen by HSJ and BBC Newsnight revealing 'the number of patients waiting three months or longer...
Following Dawn Butler MP appearance on This Morning, today, announcing her mission to find the Million Missing Mammograms, Breast Cancer Now said...
Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s absolutely fantastic news that following a provisional...
Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Today’s news that Trodelvy has finally been recommended by NICE...
In response to the news abemaciclib has been approved by NICE for routine use on the NHS with hormone therapy following surgery for certain women...
In response to research published in Genome Medicine, and part funded by Breast Cancer Now, which suggests drugs that neutralise...
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
Sign up
Connect with us
